U.S. health regulators are defending their handling of Moderna’s mRNA flu vaccine application after initially declining to review it, while signaling the decision may not be final.
La fuga di Bolsonaro dal Brasile, il super giudice e la tangente sul kolossal dedicato al padre
Ottobre 28, 2026
Read More [#item_full_content]
